ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,101 | 72.95599 | 1 |
male
| 0 | 9 | 965 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 |
$25-$50k
| 0 | 16,094 | 9,747.75 | null | 16.5 |
white
| 31.597656 | 51 | 0.629883 | 0.526978 | 1 | 0 | 0 |
no
| 0.9 | 0.7 |
no dnr
| 9 | 42 | 5.699219 | 80 | 24 | 37.5 | 359.25 | 3.899902 | 1.099854 | 8.099609 | 135 | 7.439453 | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
2,102 | 30.021 | 1 |
female
| 1 | 22 | 22 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 13 | null | 0 | 257,474 | 150,595.625 | null | 35.333313 |
white
| 26.898438 | 43 | 0.813965 | 0.751953 | 80 | 0 | 0 |
no
| 0.3 | 0.4 |
dnr after sadm
| 20 | 73 | 0.199982 | 104 | 32 | 38.19531 | null | 2.399902 | null | 0.699951 | 141 | null | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
2,103 | 66.72699 | 0 |
female
| 0 | 25 | 1,590 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 | null | 0 | 57,971 | 30,666.6406 | null | 15.666664 |
white
| 31.699219 | 42 | 0.661987 | 0.564941 | 1 | 1 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 25 | 69 | 5.199219 | 52 | 28 | 36.39844 | 169.375 | 3.199707 | null | 4.799805 | 145 | 7.349609 | null | null | null | 2 | 1 |
no(M2 and SIP pres)
| 1 |
2,104 | 72.45996 | 1 |
female
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 21,265 | 6,894.4297 | null | 32.5 |
white
| 32.09375 | 62 | 0.619995 | 0.515991 | 1 | 0 | 1 |
no
| 0.2 | 0.15 |
dnr after sadm
| 3 | 43 | 21.5 | 111 | 42 | 38.69531 | 275 | 2.399902 | 0.099991 | 0.799927 | 144 | 7.289062 | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
2,105 | 59.737 | 1 |
male
| 0 | 5 | 22 |
Lung Cancer
|
Cancer
| 1 | 14 |
$25-$50k
| 0 | 8,897 | 5,825.3672 | null | 13 |
white
| 24.597656 | 21 | 0.543945 | 0.220978 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.7 |
no dnr
| 5 | 117 | 6.5 | 120 | 25 | 36.09375 | null | 3.199707 | null | 1 | 139 | null | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
2,106 | 75.28497 | 1 |
female
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
$25-$50k
| 9 | 63,906 | 40,457 | null | 52 |
white
| 38.898438 | 46 | 0.240997 | 0.138977 | 24 | 0 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 1 | 49 | 16.097656 | 116 | 28 | 35.79688 | 163.25 | 2.699707 | 1.599854 | 1.699951 | 149 | 7.449219 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
2,107 | 60.46799 | 1 |
male
| 1 | 21 | 21 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 16 |
>$50k
| 0 | 110,493 | null | null | 46.666657 |
white
| 43.5 | 66 | 0.087997 | 0.034996 | 22 | 0 | 0 |
yes
| 0.02 | 0.000008 |
dnr after sadm
| 20 | 49 | 36.195313 | 116 | 10 | 35.39844 | 142.84375 | 2.399902 | 1.899902 | 6.099609 | 148 | 7.279297 | null | null | null | null | null |
<2 mo. follow-up
| 2.036133 |
2,108 | 86.17096 | 0 |
female
| 0 | 95 | 1,583 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 0 | 215,811 | 79,855.875 | null | 40.25 |
white
| 34.695313 | 42 | 0.414978 | 0.294983 | 3 | 0 | 0 |
no
| 0.7 | 0.9 |
no dnr
| 95 | 50 | 12.599609 | 38 | 24 | 38.89844 | 96.65625 | 3.199707 | 0.799927 | 0.799927 | 137 | 7.419922 | null | null | null | null | null | null | 3.432617 |
2,109 | 79.98395 | 1 |
male
| 1 | 6 | 6 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 14 |
>$50k
| 0 | 18,895 | 7,076.6055 | null | 45 |
white
| 42.398438 | 68 | 0.220978 | 0.071991 | 1 | 0 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 6 | 45 | 11.699219 | 150 | 35 | 35.89844 | 213.3125 | 2.399902 | 0.799927 | 1.699951 | 138 | 7.439453 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
2,110 | 53.65598 | 0 |
male
| 0 | 11 | 1,580 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 16,865 | 9,048.6797 | null | 14.5 |
hispanic
| 20.898438 | 47 | 0.875 | 0.830933 | 1 | 0 | 0 |
no
| 0.99 | 0.99 |
no dnr
| 11 | 60 | 9.699219 | 69 | 40 | 38.89844 | null | 2.299805 | 2.899902 | 1.399902 | 132 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,111 | 67.51794 | 0 |
female
| 0 | 18 | 1,579 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 23,680 | 17,051.9375 | null | 9 |
white
| 29.097656 | 58 | 0.711914 | 0.623901 | 1 | 1 | 1 |
no
| 1 | 0.1 |
no dnr
| 18 | 78 | 12 | 100 | 38 | 37.59375 | 93 | 3 | 3.299805 | 1.5 | 137 | 7.349609 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
2,112 | 83.50696 | 0 |
female
| 0 | 7 | 1,579 |
Colon Cancer
|
Cancer
| 2 | 12 | null | 0 | 8,183 | 5,498.0977 | null | 8 |
white
| 6.299805 | 18 | 0.900879 | 0.772949 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 7 | 103 | 6.899414 | 60 | 20 | 36.09375 | null | 4.399414 | 0.699951 | 1.199951 | 138 | null | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
2,113 | 68.22198 | 0 |
male
| 0 | 4 | 1,578 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
$11-$25k
| 0 | 4,646 | 3,037.4551 | null | 15 |
white
| 16.296875 | 26 | 0.887939 | 0.813965 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 80 | 7.399414 | 90 | 25 | 36.19531 | null | 4 | null | 1.699951 | 141 | null | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
2,114 | 64.72296 | 1 |
female
| 0 | 13 | 1,257 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 20,184 | 9,861.875 | null | 16.5 |
white
| 30.699219 | 39 | 0.709961 | 0.549927 | 1 | 1 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 13 | 57 | 14.699219 | 101 | 36 | 36.19531 | 116.3125 | 3 | 0.5 | 0.799927 | 136 | 7.439453 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,115 | 87.04199 | 1 |
female
| 0 | 13 | 150 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 9 | 17,585 | 8,647.2109 | null | 18 |
white
| 36.398438 | 72 | 0.360962 | 0.242981 | 1 | 0 | 1 |
no
| 0.7 | 0.5 |
no dnr
| 13 | 52 | 17 | 116 | 30 | 37.89844 | 125.70312 | 2.799805 | 0.299988 | 2.399902 | 145 | 7.449219 | null | null | null | null | 5 |
adl>=4 (>=5 if sur)
| 5 |
2,116 | 81.85895 | 1 |
female
| 0 | 15 | 1,467 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 9 | 25,693 | 18,750.5312 | null | 15.333328 |
white
| 19.398438 | 20 | 0.792969 | 0.724976 | 1 | 0 | 0 |
no
| 0.95 | 0.8 |
no dnr
| 15 | 110 | 10.898438 | 110 | 14 | 37.79688 | 240 | null | null | 0.799927 | 143 | 7.40918 | null | null | null | 1 | 2 |
no(M2 and SIP pres)
| 2 |
2,117 | 74.61694 | 1 |
female
| 1 | 9 | 9 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 9 | 19,026 | 6,393.8477 | null | 13 |
white
| 19.796875 | 43 | 0.796997 | 0.672974 | 1 | 0 | 1 |
no
| 0.5 | 0.3 |
dnr after sadm
| 8 | 65 | 12.898438 | 120 | 35 | 36.59375 | 262.5 | null | 0.699951 | 0.599976 | 141 | 7.379883 | null | null | null | null | null |
<2 mo. follow-up
| 5.261719 |
2,118 | 53.59299 | 1 |
female
| 0 | 6 | 1,344 |
Lung Cancer
|
Cancer
| 1 | 15 | null | 0 | 7,058 | 4,624.3828 | null | 15 |
white
| 10 | 14 | 0.838989 | 0.647949 | 1 | 0 | 0 |
metastatic
| 0.95 | 0.8 |
no dnr
| 6 | 103 | 13.699219 | 100 | 20 | 36.79688 | null | 4.099609 | 0.299988 | 1 | 141 | null | null | null | null | 0 | 1 |
no(M2 and SIP pres)
| 1 |
2,119 | 57.84497 | 1 |
male
| 0 | 22 | 774 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 | null | 0 | 29,955 | 20,794.0781 | null | 16 |
white
| 23 | 28 | 0.850952 | 0.753906 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 22 | 80 | 4.899414 | 127 | 25 | 35.89844 | 342.8125 | 3.699707 | 2.099609 | 1.199951 | 146 | 7.399414 | null | null | null | 2 | 0 |
no(M2 and SIP pres)
| 0 |
2,120 | 78.60596 | 1 |
male
| 0 | 15 | 1,550 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 18 | null | 0 | 18,683 | 11,155.7188 | null | 11.666664 |
white
| 20.097656 | 28 | 0.815918 | 0.754883 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 15 | 109 | 11.5 | 73 | 26 | 39.69531 | null | 4 | 1.099854 | 1.399902 | 133 | null | null | null | null | 1 | 5 |
no(M2 and SIP pres)
| 5 |
2,121 | 43.38898 | 0 |
male
| 0 | 17 | 1,568 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 0 | 25,196 | 13,795.8359 | null | 13.333328 |
black
| 19.398438 | 20 | 0.907959 | 0.875 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 17 | 65 | 6.099609 | 110 | 20 | 37.89844 | 420 | 3.199707 | 1.399902 | 0.699951 | 139 | 7.389648 | null | null | null | 0 | 0 | null | 0 |
2,122 | 59.34799 | 1 |
male
| 0 | 18 | 113 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
>$50k
| 0 | 29,852 | 14,541.1406 | null | 20 |
white
| 30 | 31 | 0.671997 | 0.575928 | 1 | 0 | 0 |
yes
| 0.3 | 0.1 |
no dnr
| 18 | 55 | 13.199219 | 68 | 13 | 35.59375 | 128.3125 | 3.699707 | 1.299805 | 0.899902 | 140 | 7.459961 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
2,123 | 78.67798 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 12 | null | 37 | 19,026 | 6,859.6016 | null | 37.5 |
white
| 21.398438 | 49 | 0.679932 | 0.585938 | 1 | 1 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 7 | 59 | 7.399414 | 60 | 8 | 37.69531 | 390 | 2.099609 | 0.699951 | 3.5 | 147 | 7.439453 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
2,124 | 75.52899 | 0 |
female
| 0 | 13 | 1,570 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 13,975 | 9,379.8125 | null | 12 |
white
| 18.5 | 38 | 0.846924 | 0.747925 | 1 | 0 | 0 |
no
| 0.2 | 0.5 |
no dnr
| 13 | 73 | 4.199219 | 80 | 20 | 37 | 224 | null | null | 2.399902 | 136 | 7.479492 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,125 | 47.59198 | 0 |
male
| 0 | 27 | 1,570 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
$25-$50k
| 0 | 57,841 | 33,688.0625 | null | 19.75 |
white
| 27 | 34 | 0.822998 | 0.763916 | 1 | 0 | 0 |
no
| 0.4 | 0.4 |
no dnr
| 27 | 113 | 22.296875 | 136 | 10 | 39.39844 | 275.5 | 2.5 | 2 | 2 | 147 | 7.349609 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
2,126 | 82.63696 | 1 |
female
| 0 | 88 | 137 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 15 |
under $11k
| 0 | 87,279 | 55,067.1875 | null | 8.75 |
white
| 15.298828 | 34 | 0.794922 | 0.670898 | 6 | 0 | 0 |
no
| 0.85 | 0.8 |
dnr after sadm
| 1 | 60 | 9.099609 | 74 | 34 | 36.5 | 192.5625 | 3.799805 | 0.5 | 0.899902 | 139 | 7.489258 | null | null | null | 2 | null |
adl>=4 (>=5 if sur)
| 1.839 |
2,127 | 68.87097 | 0 |
female
| 0 | 6 | 1,564 |
Lung Cancer
|
Cancer
| 2 | 12 |
under $11k
| 0 | 8,578 | 5,081.6016 | null | 7 |
white
| 17.5 | 16 | 0.688965 | 0.396973 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 6 | 83 | 4.5 | 100 | 20 | 38.09375 | null | 3.299805 | 0.699951 | 0.799927 | 136 | 7.539062 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,128 | 83.11597 | 1 |
male
| 0 | 22 | 135 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 0 | 27,727 | 15,532.4844 | null | 18.333328 |
white
| 30.398438 | 34 | 0.599976 | 0.492981 | 1 | 0 | 1 |
no
| 0.7 | 0.5 |
dnr after sadm
| 2 | 53 | 14.5 | 63 | 24 | 36.09375 | 103.32812 | 3.199707 | 0.799927 | 1.099854 | 145 | 7.479492 | null | null | null | null | 4 |
adl>=4 (>=5 if sur)
| 4 |
2,129 | 70.21997 | 1 |
female
| 1 | 4 | 4 |
Coma
|
Coma
| 1 | 14 |
>$50k
| 0 | 14,317 | 6,209.9922 | null | 49 |
white
| 60.195313 | 90 | 0 | 0 | 1 | 1 | 0 |
no
| null | null |
dnr after sadm
| 3 | 42 | 11.898438 | 108 | 9 | 32.29688 | 54 | 2.199707 | 4.399414 | 2.799805 | 136 | 7.449219 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
2,130 | 65.92999 | 0 |
male
| 0 | 45 | 1,561 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 16 |
$25-$50k
| 0 | 88,955 | 50,380.625 | null | 27.25 |
white
| 28.5 | 50 | 0.72998 | 0.646973 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 45 | 57 | 10.5 | 170 | 28 | 38.69531 | 138 | null | null | 1 | 142 | 7.429688 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
2,131 | 50.97598 | 0 |
male
| 0 | 74 | 1,560 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 18 |
under $11k
| 37 | 74,681 | 47,597.1562 | null | 8.25 |
black
| 21.296875 | 15 | 0.753906 | 0.675903 | 1 | 1 | 0 |
yes
| 0.7 | 0.5 |
no dnr
| 74 | 82 | 10.099609 | 106 | 26 | 36 | 225 | 2.5 | 0.299988 | 0.899902 | 134 | 7.449219 | null | null | null | null | null |
no(M2 and SIP pres)
| 3.289551 |
2,132 | 43.047 | 0 |
female
| 0 | 5 | 1,560 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 18 | null | 0 | 6,616 | 4,769.8359 | null | 8 | null | 19.097656 | 31 | 0.938965 | 0.894897 | 1 | 0 | 0 |
no
| 0.98 | 0.98 |
no dnr
| 5 | 107 | 9.798828 | 70 | 25 | 35.59375 | 214.28125 | null | null | 1 | 143 | 7.429688 | null | null | null | 1 | null |
no(M2 and SIP pres)
| 1.1669 |
2,133 | 54.793 | 1 |
female
| 1 | 27 | 27 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 48,801 | 29,029.0938 | null | 20.5 |
white
| 30.796875 | 64 | 0.552979 | 0.439941 | 1 | 0 | 0 |
yes
| 0.6 | 0.5 |
dnr after sadm
| 22 | 123 | 0.099991 | 170 | 38 | 39.59375 | null | 2.5 | 0.699951 | 1.099854 | 144 | null | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
2,134 | 59.64398 | 1 |
female
| 1 | 8 | 8 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 20,609 | null | null | 37.5 |
hispanic
| 37.898438 | 35 | 0.253967 | 0.148987 | 1 | 0 | 0 |
metastatic
| 0.15 | 0.08 |
dnr after sadm
| 5 | 45 | 6.299805 | 112 | 38 | 37.89844 | 118.32812 | 3.099609 | null | 0.599976 | 138 | 7.30957 | null | null | null | 0 | 0 |
<2 mo. follow-up
| 0 |
2,135 | 75.45795 | 0 |
female
| 0 | 55 | 1,556 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 0 | 207,683 | 103,477.188 | null | 37.5 |
white
| 30 | 56 | 0.554932 | 0.441956 | 15 | 0 | 0 |
no
| null | null |
dnr after sadm
| 9 | 123 | 7.399414 | 101 | 8 | 38.59375 | 79 | 3 | null | 2.199707 | 154 | 7.459961 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
2,136 | 75.65198 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 0 | 32,199 | 21,257.1094 | null | 47 |
white
| 26.597656 | 25 | 0.635986 | 0.534912 | 16 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 68 | 9.699219 | 125 | 20 | 39.39844 | 132 | null | null | 0.699951 | 139 | 7.419922 | null | null | null | null | null |
<2 mo. follow-up
| 2.556152 |
2,137 | 79.27698 | 0 |
female
| 0 | 12 | 1,556 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 10 |
under $11k
| 0 | 14,304 | 8,597.7031 | null | 18.5 |
white
| 20.597656 | 27 | 0.778931 | 0.646973 | 1 | 0 | 0 |
no
| 0.75 | 0.5 |
dnr after sadm
| 1 | 60 | 16.296875 | 100 | 20 | 37.79688 | 311.625 | 3.299805 | 0.699951 | 1.699951 | 135 | 7.399414 | null | null | null | null | 5 |
adl>=4 (>=5 if sur)
| 5 |
2,138 | 73.51996 | 1 |
female
| 0 | 5 | 32 |
Lung Cancer
|
Cancer
| 3 | 12 |
under $11k
| 0 | 6,003 | 3,975.2188 | null | 4 |
white
| 17.796875 | 14 | 0.669922 | 0.370972 | 1 | 1 | 0 |
metastatic
| 0.9 | 0.8 |
dnr after sadm
| 3 | 100 | 21.898438 | 80 | 20 | 36.69531 | null | null | 0.699951 | 0.599976 | 136 | 7.439453 | null | null | null | 1 | 0 |
<2 mo. follow-up
| 0 |
2,139 | 41.52197 | 1 |
male
| 0 | 12 | 97 |
Lung Cancer
|
Cancer
| 2 | 11 | null | 0 | 15,020 | 9,517.5469 | null | 10.5 |
white
| 9.798828 | 14 | 0.85791 | 0.68396 | 1 | 1 | 0 |
metastatic
| 0.75 | 0.1 |
no dnr
| 12 | 101 | 6.5 | 72 | 14 | 35.89844 | null | 4 | 0.899902 | 1 | 141 | null | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
2,140 | 81.25098 | 1 |
female
| 0 | 38 | 78 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 100 | 45,228 | 32,094.3125 | null | 17 |
white
| 24.398438 | 49 | 0.21698 | 0.069992 | 1 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 1 | 67 | 4.399414 | 63 | 38 | 36.69531 | 257.125 | 3.299805 | 0.399963 | 3.399902 | 144 | 7.259766 | null | null | null | null | null |
SIP>=30
| 4.545898 |
2,141 | 46.59497 | 0 |
male
| 0 | 17 | 1,551 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 15 |
under $11k
| 0 | 21,756 | 11,337.4766 | null | 11.333328 |
white
| 42.09375 | 66 | 0.359985 | 0.167999 | 2 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 7 | 57 | 12.099609 | 118 | 24 | 36.09375 | 328.5625 | 2.899902 | 36.5 | 5.399414 | 136 | 7.40918 | null | null | null | 1 | 1 |
no(M2 and SIP pres)
| 1 |
2,142 | 77.52496 | 1 |
male
| 0 | 10 | 246 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 18 | null | 0 | 16,099 | 8,107.6133 | null | 17 |
white
| 34.09375 | 63 | 0.416992 | 0.296997 | 1 | 0 | 0 |
yes
| 0.9 | 0.7 |
no dnr
| 10 | 110 | 0.899902 | 110 | 28 | 36.09375 | 270 | 2.899902 | 3.799805 | 1.699951 | 136 | 7.479492 | null | null | null | null | 0 | null | 0 |
2,143 | 56.71997 | 0 |
male
| 0 | 8 | 1,550 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 22 | null | 0 | 16,069 | 6,561.6797 | null | 16 |
white
| 26.296875 | 45 | 0.80188 | 0.736938 | 1 | 0 | 0 |
no
| 0.99 | 0.9 |
no dnr
| 8 | 135 | 11.099609 | 142 | 68 | 37.79688 | 205 | 3.399902 | 1.599854 | 1.099854 | 142 | 7.449219 | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
2,144 | 70.73499 | 1 |
male
| 0 | 58 | 1,236 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 8 |
>$50k
| 0 | 61,059 | 35,104.8438 | null | 6.75 |
white
| 24.199219 | 36 | 0.725952 | 0.641968 | 9 | 0 | 0 |
no
| null | null |
no dnr
| 58 | 61 | 7.099609 | 52 | 28 | 37.89844 | 151 | null | null | 1.599854 | 134 | 7.369141 | null | null | null | 0 | 2 |
no(M2 and SIP pres)
| 2 |
2,145 | 77.53296 | 0 |
female
| 0 | 7 | 1,550 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
under $11k
| 0 | 10,496 | 5,027.7578 | null | 19 |
white
| 23.199219 | 57 | 0.747925 | 0.602905 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 67 | 26.097656 | 132 | 42 | 36.19531 | 223.78125 | 3.899902 | null | 1 | 138 | 7.329102 | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
2,146 | 85.20496 | 1 |
male
| 0 | 7 | 299 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 21,089 | 11,513.1719 | null | 17 |
white
| 22.097656 | 36 | 0.552979 | 0.35498 | 11 | 0 | 0 |
yes
| 0.9 | 0.5 |
no dnr
| 7 | 56 | 5.199219 | 70 | 25 | 36.09375 | 175.5 | null | null | 1 | 140 | 7.359375 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
2,147 | 47.61398 | 0 |
female
| 0 | 5 | 1,547 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 0 | 11,252 | 4,251.1133 | null | 13 |
white
| 18.597656 | 18 | 0.898926 | 0.861938 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 5 | 63 | 6.699219 | 72 | 24 | 37.79688 | 137.5 | null | 0.5 | 0.899902 | 143 | 7.569336 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
2,148 | 75.78094 | 1 |
female
| 0 | 12 | 49 |
MOSF w/Malig
|
ARF/MOSF
| 2 | null | null | 0 | 30,913 | 15,681.8906 | null | 20.5 |
white
| 36.5 | 62 | 0.235992 | 0.134979 | 14 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 2 | 51 | 58.195313 | 59 | 26 | 35.29688 | 197.5 | 3.099609 | 2.199707 | 2 | 132 | 7.40918 | null | null | null | null | null |
<2 mo. follow-up
| 2.98291 |
2,149 | 74.95697 | 1 |
male
| 1 | 48 | 48 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
>$50k
| 0 | 131,184 | 100,893.625 | null | 39.25 |
white
| 23.5 | 30 | 0.751953 | 0.67395 | 3 | 0 | 0 |
no
| 0.8 | 0.8 |
dnr after sadm
| 18 | 123 | 10.199219 | 80 | 6 | 36.29688 | 121.65625 | null | null | 1.5 | 138 | 7.479492 | null | null | null | null | null |
<2 mo. follow-up
| 2.132813 |
2,150 | 74.32196 | 1 |
male
| 0 | 4 | 234 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
$11-$25k
| 0 | 3,623 | 2,212.6562 | null | 5 |
white
| 15.298828 | 36 | 0.882935 | 0.804932 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 97 | 11.5 | 70 | 32 | 37.09375 | 400 | 4 | 0.699951 | 2 | 142 | 7.489258 | null | null | null | 2 | 1 |
SIP>=30
| 1 |
2,151 | 64.19696 | 1 |
female
| 1 | 34 | 34 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 104,074 | 35,145.8438 | null | 41.5 |
white
| 36.898438 | 39 | 0.465942 | 0.346985 | 1 | 0 | 0 |
yes
| 0.75 | 0.6 |
dnr after sadm
| 9 | 46 | 19.199219 | 123 | 12 | 39.09375 | 175 | 3.599609 | null | 0.299988 | 137 | 7.379883 | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
2,152 | 58.65799 | 1 |
male
| 0 | 17 | 153 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
$11-$25k
| 0 | 21,228 | 11,682.9922 | null | 11 |
white
| 13.599609 | 18 | 0.932983 | 0.885986 | 1 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 17 | 73 | 11.099609 | 80 | 20 | 35.59375 | 196.65625 | 4.399414 | null | 1.099854 | 141 | 7.359375 | null | null | null | 1 | 0 |
SIP>=30
| 0 |
2,153 | 93.34998 | 1 |
male
| 0 | 17 | 462 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 9 | 22,396 | 12,064.6797 | null | 12 |
white
| 19.699219 | 28 | 0.741943 | 0.661987 | 1 | 1 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 17 | 70 | 7.5 | 58 | 8 | 36.09375 | 325 | null | 1.699951 | 1.699951 | 143 | 7.369141 | null | null | null | null | null | null | 4.532227 |
2,154 | 67.10199 | 1 |
male
| 1 | 22 | 22 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 | null | 0 | 26,499 | 16,922.2969 | null | 13 |
white
| 21.898438 | 29 | 0.833984 | 0.728882 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 22 | 117 | 11.798828 | 100 | 20 | 36.09375 | 368 | 4 | 0.799927 | 2.799805 | 135 | 7.519531 | null | null | null | null | 2 |
<2 mo. follow-up
| 2 |
2,155 | 51.45499 | 0 |
female
| 0 | 14 | 1,543 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 13 |
under $11k
| 0 | 36,074 | 15,445.6406 | null | 31.333328 |
white
| 25 | 26 | 0.815918 | 0.754883 | 3 | 1 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 14 | 67 | 6.799805 | 62 | 8 | 36.09375 | 141.40625 | 2.599609 | 1.399902 | 0.599976 | 134 | 7.389648 | null | null | null | null | 3 |
no(M2 and SIP pres)
| 3 |
2,156 | 65.08698 | 0 |
male
| 0 | 5 | 1,543 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 5,422 | 2,610.7871 | null | 14 |
white
| 15.398438 | 13 | 0.902954 | 0.836914 | 1 | 1 | 0 |
no
| 0.7 | 0.5 |
no dnr
| 5 | 83 | 7.799805 | 100 | 20 | 37.79688 | 648.125 | null | null | 1.199951 | 136 | 7.40918 | null | null | null | null | null | null | 2.595703 |
2,157 | 84.48199 | 1 |
male
| 1 | 106 | 106 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 6 |
$11-$25k
| 0 | 227,626 | 151,603 | null | 25.75 |
white
| 22.097656 | 29 | 0.679932 | 0.509888 | 3 | 0 | 0 |
no
| 1 | 1 |
no dnr
| 106 | 107 | 16.398438 | 120 | 32 | 37.79688 | 223 | null | null | 1.299805 | 146 | 7.389648 | null | null | null | 1 | 0 |
adl>=4 (>=5 if sur)
| 0 |
2,158 | 42.82797 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 15 |
under $11k
| 0 | 16,096 | 8,934.75 | null | 40 |
black
| 52 | 92 | 0.256958 | 0.151978 | 1 | 0 | 0 |
no
| 0 | 0 |
no dnr
| 4 | 40 | 32.195313 | 135 | 37 | 35.69531 | 125 | 2.199707 | 5.699219 | 8.298828 | 143 | 7.269531 | null | null | null | null | null |
<2 mo. follow-up
| 1.983154 |
2,159 | 80.45697 | 1 |
female
| 1 | 10 | 10 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 13 | null | 0 | 12,819 | 7,515.3398 | null | 23.5 |
white
| 48.59375 | 71 | 0.056 | 0.018997 | 1 | 0 | 0 |
yes
| 0.1 | 0.001 |
dnr after sadm
| 2 | 46 | 0.099991 | 128 | 35 | 36.29688 | 190 | 3.399902 | 2.099609 | 0.899902 | 127 | 7.469727 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
2,160 | 58.28598 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 0 | 34,635 | 20,541.2812 | null | 46 |
white
| 47.59375 | 72 | 0.231995 | 0.131989 | 3 | 1 | 0 |
no
| null | null |
dnr after sadm
| 3 | 43 | 35.5 | 120 | 14 | 40.39844 | 106.65625 | 2.099609 | null | 2.399902 | 131 | 7.399414 | null | null | null | null | null |
<2 mo. follow-up
| 2.449219 |
2,161 | 67.01196 | 1 |
male
| 1 | 19 | 19 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 94,528 | 71,583.0625 | null | 45.666657 |
white
| 32.09375 | 54 | 0.563965 | 0.451965 | 10 | 1 | 0 |
no
| 0.85 | 0.85 |
no dnr
| 19 | 55 | 21.398438 | 120 | 12 | 38.59375 | 186 | null | null | 4.199219 | 140 | 7.359375 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
2,162 | 70.03998 | 1 |
female
| 0 | 12 | 151 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 12,519 | 7,553.4453 | null | 6.5 |
white
| 15.099609 | 21 | 0.73291 | 0.462952 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 1 | 77 | 5.799805 | 70 | 25 | 36.09375 | null | 3.799805 | 1.399902 | 0.699951 | 143 | null | null | null | null | null | null | null | 2.902344 |
2,163 | 99.28497 | 1 |
male
| 1 | 53 | 53 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 17 | null | 0 | 118,924 | 35,281.5938 | null | 34.5 |
white
| 33.398438 | 43 | 0.389954 | 0.19397 | 1 | 0 | 1 |
no
| 0.3 | 0.2 |
no dnr
| 53 | 45 | 13.199219 | 70 | 10 | 36.39844 | 212.5 | null | 1.699951 | 2.299805 | 132 | 7.489258 | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
2,164 | 52.504 | 1 |
female
| 0 | 11 | 927 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 12 | null | 0 | 15,466 | 7,561.2266 | null | 13 |
white
| 23.097656 | 22 | 0.855957 | 0.762939 | 1 | 0 | 0 |
yes
| 1 | 0.95 |
no dnr
| 11 | 71 | 19.398438 | 140 | 24 | 36.09375 | 288 | null | null | 0.899902 | 143 | 7.329102 | null | null | null | 2 | 1 |
no(M2 and SIP pres)
| 1 |
2,165 | 68.99097 | 1 |
female
| 1 | 8 | 8 |
Colon Cancer
|
Cancer
| 1 | 6 |
$25-$50k
| 0 | 9,864 | 6,236.082 | null | 18 |
white
| 32.898438 | 36 | 0.463989 | 0.148987 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.1 |
dnr after sadm
| 1 | 53 | 7.699219 | 72 | 10 | 35.79688 | null | 2.5 | 0.599976 | 1.099854 | 137 | null | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
2,166 | 59.49298 | 1 |
female
| 0 | 26 | 668 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 40,197 | 20,480.5469 | null | 18 |
black
| 25.597656 | 40 | 0.802979 | 0.736938 | 1 | 0 | 0 |
no
| 1 | 0.8 |
no dnr
| 26 | 137 | 18.097656 | 119 | 32 | 35.79688 | 273.4375 | 5 | 0.599976 | 1.5 | 138 | 7.359375 | null | null | null | 0 | 0 | null | 0 |
2,167 | 86.61694 | 1 |
male
| 0 | 13 | 1,494 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 0 | 16,228 | 8,260.2891 | null | 16.5 |
white
| 25.398438 | 42 | 0.694946 | 0.603882 | 1 | 0 | 0 |
no
| 1 | 0.7 |
no dnr
| 13 | 53 | 12.699219 | 66 | 32 | 36.09375 | 280 | 4.5 | 1.799805 | 1.299805 | 143 | 7.40918 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,168 | 26.56 | 1 |
female
| 1 | 15 | 15 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 16 | null | 0 | 97,294 | 45,422.125 | null | 54.666657 |
white
| 35.398438 | 34 | 0.396973 | 0.277954 | 6 | 0 | 0 |
yes
| 0.2 | 0.2 |
dnr after sadm
| 15 | 49 | 5.5 | 118 | 10 | 36.39844 | 137.5 | 2.199707 | 1.299805 | 0.699951 | 144 | 7.399414 | null | null | null | null | null |
<2 mo. follow-up
| 2.128906 |
2,169 | 51.39999 | 0 |
male
| 0 | 15 | 1,531 |
Coma
|
Coma
| 1 | 12 |
$25-$50k
| 0 | 28,600 | 11,534.4531 | null | 29 |
white
| 38.296875 | 46 | 0.441956 | 0.367981 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 15 | 47 | 4.199219 | 126 | 10 | 38.29688 | 88 | null | 2 | 0.599976 | 133 | 7.449219 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
2,170 | 70.62598 | 1 |
female
| 0 | 29 | 1,114 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6 | 12 |
under $11k
| 0 | 82,196 | 63,520.0625 | null | 24.75 |
white
| 21.296875 | 32 | 0.779907 | 0.707886 | 8 | 1 | 0 |
no
| 0.8 | 0.2 |
no dnr
| 29 | 71 | 7.099609 | 62 | 24 | 36.69531 | 266.625 | null | 0.399963 | 3.899902 | 141 | 7.489258 | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
2,171 | 44.17499 | 1 |
male
| 0 | 35 | 51 |
Colon Cancer
|
Cancer
| 2 | 13 |
$11-$25k
| 26 | 45,066 | 26,888.6406 | null | 19.5 |
white
| 37.398438 | 23 | 0.293945 | 0.047997 | 1 | 0 | 0 |
metastatic
| 0.75 | 0.3 |
no dnr
| 35 | 66 | 9.398438 | 116 | 24 | 38.89844 | 504.75 | 2.099609 | 1 | 0.599976 | 134 | 7.439453 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
2,172 | 75.01996 | 1 |
male
| 0 | 12 | 33 |
MOSF w/Malig
|
ARF/MOSF
| 3 | 12 |
$25-$50k
| 0 | 24,165 | 8,863.8125 | null | 39.5 |
white
| 27.398438 | 37 | 0.527954 | 0.411987 | 1 | 0 | 0 |
metastatic
| 0.2 | 0.1 |
no dnr
| 12 | 57 | 5.099609 | 51 | 10 | 38 | 150 | 4.099609 | 0.899902 | 1.699951 | 144 | 7.149414 | null | null | null | 0 | 3 |
<2 mo. follow-up
| 3 |
2,173 | 69.09796 | 0 |
male
| 0 | 7 | 1,528 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 26 | 18,468 | 13,271.6875 | null | 19 |
white
| 26.296875 | 28 | 0.629883 | 0.526978 | 3 | 0 | 1 |
no
| 0.95 | 0.85 |
no dnr
| 7 | 63 | 7.399414 | 100 | 9 | 36.29688 | 113 | 2.899902 | 1 | 1.299805 | 135 | 7.489258 | null | null | null | null | null | null | 4.816406 |
2,174 | 79.66095 | 0 |
female
| 0 | 8 | 1,527 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 | null | 0 | 26,312 | 13,002.9297 | null | 18 |
white
| 17.796875 | 29 | 0.830933 | 0.773926 | 2 | 0 | 0 |
no
| 0.93 | 0.85 |
no dnr
| 8 | 54 | 10 | 67 | 16 | 38 | 236.71875 | 2.5 | null | 0.899902 | 142 | 7.449219 | null | null | null | 0 | 0 | null | 0 |
2,175 | 81.23798 | 1 |
male
| 0 | 4 | 204 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
$11-$25k
| 0 | 3,806 | 2,219.1094 | null | 7 |
white
| 22.296875 | 20 | 0.772949 | 0.637939 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 4 | 83 | 11 | 60 | 20 | 35.59375 | 336 | null | null | 1.899902 | 142 | 7.5 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,176 | 71.30695 | 1 |
female
| 0 | 18 | 207 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
$11-$25k
| 0 | 31,908 | 23,415.7656 | null | 31.666656 |
white
| 27.699219 | 44 | 0.664917 | 0.490967 | 1 | 1 | 0 |
yes
| 0.5 | 0.4 |
no dnr
| 18 | 64 | 15.898438 | 72 | 30 | 39.19531 | 68 | null | null | 1.199951 | 133 | 7.469727 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
2,177 | 82.39294 | 0 |
male
| 0 | 8 | 1,524 |
MOSF w/Malig
|
ARF/MOSF
| 3 | 9 |
$11-$25k
| 0 | 9,332 | 5,003.9336 | null | 8 |
white
| 16.296875 | 44 | 0.80896 | 0.745972 | 1 | 1 | 0 |
yes
| 0.95 | 0.8 |
no dnr
| 8 | 73 | 8.898438 | 70 | 25 | 37.79688 | 188 | 3.199707 | null | 1.099854 | 142 | 7.399414 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,178 | 71.00098 | 1 |
female
| 1 | 16 | 16 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | null |
$11-$25k
| 0 | 20,870 | 11,380.0078 | null | 15 |
white
| 27.398438 | 57 | 0.658936 | 0.483948 | 1 | 0 | 0 |
yes
| 0.3 | 0.1 |
dnr after sadm
| 2 | 103 | 6.699219 | 70 | 30 | 37.79688 | 100 | 3.099609 | 0.299988 | 1.599854 | 132 | 7.459961 | null | null | null | 6 | 6 |
<2 mo. follow-up
| 6 |
2,179 | 91.03894 | 1 |
male
| 0 | 17 | 87 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 10 |
$11-$25k
| 0 | 27,902 | 12,191.4844 | null | 13 |
white
| 27.898438 | 41 | 0.506958 | 0.305969 | 1 | 0 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 3 | 97 | 9.599609 | 120 | 50 | 37.19531 | 175.5 | 3.299805 | null | 1.299805 | 144 | 7.379883 | null | null | null | null | 3 |
SIP>=30
| 3 |
2,180 | 48.78 | 1 |
female
| 0 | 7 | 84 |
Lung Cancer
|
Cancer
| 1 | 10 |
under $11k
| 0 | 10,689 | 6,053.1328 | null | 13 |
white
| 22.898438 | 21 | 0.619995 | 0.305969 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 7 | 61 | 5 | 120 | 24 | 36.89844 | null | 3.199707 | 0.299988 | 0.699951 | 145 | 7.469727 | null | null | null | null | 0 |
SIP>=30
| 0 |
2,181 | 76.18597 | 1 |
male
| 0 | 10 | 37 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 10 |
under $11k
| 0 | 25,469 | 20,858.3125 | null | 16 |
black
| 33.398438 | 47 | 0.482971 | 0.36499 | 7 | 0 | 0 |
no
| 0.65 | 0.5 |
dnr after sadm
| 1 | 54 | 10.398438 | 71 | 24 | 35 | 432 | null | 0.5 | 2.399902 | 125 | 7.509766 | null | null | null | 7 | 2 |
<2 mo. follow-up
| 2 |
2,182 | 84.62994 | 1 |
female
| 0 | 5 | 24 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 9 | null | 9 | 6,414 | 3,839.3555 | null | 13 |
white
| 20.199219 | 36 | 0.717896 | 0.560913 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
dnr before sadm
| -1 | 80 | 9.898438 | 60 | 30 | 36.09375 | 190.46875 | 3.599609 | null | 1.199951 | 138 | 7.449219 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
2,183 | 93.62897 | 1 |
female
| 0 | 4 | 624 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 9 | 4,975 | 2,718.4961 | null | 8 |
white
| 17.296875 | 25 | 0.773926 | 0.639893 | 1 | 0 | 0 |
no
| 0.75 | 0.6 |
dnr after sadm
| 1 | 67 | 5.799805 | 70 | 20 | 36.09375 | null | null | null | 0.899902 | 132 | 7.389648 | null | null | null | null | null | null | 4.31543 |
2,184 | 86.18799 | 1 |
female
| 1 | 23 | 23 |
Lung Cancer
|
Cancer
| 1 | 12 |
under $11k
| 0 | 26,902 | 16,868.9062 | null | 9.666664 |
black
| 27.398438 | 27 | 0.375 | 0.087997 | 1 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
dnr after sadm
| 2 | 100 | 8.699219 | 100 | 25 | 36.09375 | null | 3 | 0.399963 | 0.699951 | 131 | null | null | null | null | null | 3 |
<2 mo. follow-up
| 3 |
2,185 | 76.53894 | 1 |
female
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 56,726 | 19,535.5 | null | 33.666657 |
white
| 31 | 50 | 0.416992 | 0.297974 | 3 | 0 | 0 |
metastatic
| 0.5 | 0.1 |
dnr after sadm
| 11 | 50 | 9.798828 | 48 | 42 | 38 | 170 | 3.199707 | null | 0.699951 | 134 | 7.419922 | null | null | null | null | 2 |
<2 mo. follow-up
| 2 |
2,186 | 80.79095 | 0 |
female
| 0 | 8 | 1,521 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 21,055 | 10,767.7969 | null | 10 |
white
| 14.199219 | 15 | 0.820923 | 0.708984 | 6 | 0 | 0 |
no
| 0.95 | 0.8 |
no dnr
| 8 | 83 | 12.898438 | 80 | 20 | 38 | 390 | null | null | 0.899902 | 144 | 7.389648 | null | null | null | 0 | 1 |
no(M2 and SIP pres)
| 1 |
2,187 | 49.85397 | 1 |
male
| 0 | 14 | 54 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 31,619 | 9,491.9141 | null | 35.333313 |
white
| 39.296875 | 39 | 0.493958 | 0.375977 | 1 | 0 | 0 |
yes
| 0.3 | 0.3 |
no dnr
| 14 | 43 | 11.398438 | 114 | 10 | 39.29688 | 154 | 2.299805 | 0.599976 | 0.299988 | 147 | 7.389648 | null | null | null | null | null |
<2 mo. follow-up
| 2.375488 |
2,188 | 94.10797 | 1 |
female
| 0 | 23 | 27 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 9 | 21,424 | 12,836.1719 | null | 13.333328 |
white
| 13.199219 | 24 | 0.836914 | 0.781982 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 1 | 70 | 9.298828 | 80 | 20 | 36.69531 | 295 | null | 0.399963 | 1.099854 | 140 | 7.299805 | null | null | null | 4 | null |
<2 mo. follow-up
| 3.183199 |
2,189 | 97.83997 | 1 |
male
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 49,040 | 36,014.4375 | null | 39.5 |
white
| 24.097656 | 47 | 0.594971 | 0.487 | 7 | 0 | 1 |
no
| 0.2 | 0.2 |
dnr after sadm
| 6 | 103 | 8.199219 | 105 | 48 | 37.59375 | 124 | 2 | 1 | 1.299805 | 142 | 7.469727 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
2,190 | 66.51294 | 1 |
male
| 0 | 7 | 803 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 8,567 | 6,116.7656 | null | 20 |
white
| 22.5 | 19 | 0.778931 | 0.707886 | 1 | 0 | 0 |
yes
| 0.9 | 0.9 |
no dnr
| 7 | 72 | 8.898438 | 60 | 16 | 36.19531 | 140 | 5.199219 | 1.799805 | 1.099854 | 137 | 7.359375 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,191 | 29.618 | 0 |
female
| 0 | 23 | 1,512 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 | null | 0 | 69,945 | 27,965.0312 | null | 25 |
white
| 22 | 25 | 0.881958 | 0.840942 | 13 | 0 | 0 |
no
| 0.98 | 0.98 |
no dnr
| 23 | 58 | 6.5 | 124 | 8 | 38.09375 | 353.3125 | 3.599609 | null | 0.599976 | 136 | 7.449219 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
2,192 | 72.10095 | 1 |
male
| 0 | 5 | 833 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 12 |
$11-$25k
| 0 | 4,571 | 2,801.9727 | null | 7 |
white
| 19.898438 | 45 | 0.840942 | 0.73999 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 5 | 120 | 11.398438 | 80 | 25 | 35.59375 | null | 4.199219 | 0.599976 | 2.799805 | 139 | null | null | null | null | 2 | null | null | 1.839 |
2,193 | 43.16998 | 0 |
male
| 0 | 34 | 1,514 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 97,562 | 64,663.4688 | null | 33.5 |
white
| 27.5 | 35 | 0.807983 | 0.743896 | 3 | 1 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 34 | 60 | 12.398438 | 58 | 12 | 39.59375 | 97.14062 | null | 0.599976 | 1.5 | 146 | 7.429688 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
2,194 | 80.01599 | 1 |
female
| 1 | 31 | 31 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 105,850 | 78,684 | null | 38.25 |
white
| 31.296875 | 46 | 0.506958 | 0.389954 | 9 | 1 | 0 |
no
| 0.05 | 0.000125 |
dnr before sadm
| -3 | 62 | 13 | 62 | 8 | 37.79688 | 153.3125 | null | null | 4.5 | 128 | 7.389648 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
2,195 | 54.26099 | 1 |
female
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 13,516 | 6,553.5938 | null | 19 |
black
| 32.59375 | 56 | 0.420959 | 0.301941 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 4 | 53 | 19.597656 | 74 | 22 | 37.69531 | 386.625 | 2.599609 | 8.599609 | 2.899902 | 149 | 7.359375 | null | null | null | null | 2 |
<2 mo. follow-up
| 2 |
2,196 | 54.33499 | 1 |
female
| 0 | 12 | 1,021 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 9 |
under $11k
| 9 | 18,839 | 7,886.2734 | null | 22 |
black
| 35.898438 | 43 | 0.56897 | 0.457947 | 2 | 1 | 0 |
no
| 1 | 1 |
no dnr
| 12 | 45 | 10.798828 | 118 | 28 | 39.09375 | 490.4375 | 2.699707 | null | 1.899902 | 153 | 7.40918 | null | null | null | 0 | 2 |
no(M2 and SIP pres)
| 2 |
2,197 | 85.16095 | 1 |
female
| 1 | 25 | 25 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
$25-$50k
| 9 | 27,344 | 17,588.2812 | null | 11.666664 |
white
| 28.597656 | 52 | 0.587891 | 0.395996 | 1 | 1 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 5 | 57 | 7 | 56 | 20 | 34.79688 | 396 | 3.399902 | 1.5 | 2.899902 | 142 | 7.419922 | null | null | null | 5 | null |
<2 mo. follow-up
| 3.855299 |
2,198 | 52.19199 | 1 |
female
| 0 | 16 | 1,059 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
>$50k
| 0 | 20,742 | 10,266.4219 | null | 11.666664 |
white
| 18.199219 | 31 | 0.900879 | 0.86499 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 16 | 103 | 9.599609 | 66 | 22 | 36 | 403.6875 | 3.299805 | 0.5 | 12.398438 | 143 | 7.379883 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,199 | 74.72095 | 0 |
male
| 0 | 6 | 1,507 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 |
$25-$50k
| 0 | 6,934 | 3,570.0644 | null | 9 |
white
| 13 | 27 | 0.899902 | 0.862915 | 1 | 1 | 0 |
no
| 0.99 | 0.99 |
no dnr
| 6 | 120 | 8.199219 | 80 | 20 | 37.5 | 309 | 4.399414 | 0.299988 | 1.5 | 142 | 7.279297 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
2,200 | 88.32898 | 1 |
male
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 | null | 0 | 21,473 | 7,042.2812 | null | 45.5 |
white
| 34.398438 | 35 | 0.428955 | 0.309998 | 2 | 0 | 0 |
no
| 0.3 | 0.3 |
no dnr
| 8 | 40 | 13.398438 | 55 | 10 | 37.19531 | 192.5 | 2.5 | null | 1.399902 | 133 | 7.489258 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.